NTrans Technologies BV

Natural delivery to unlock the full potential of cell and gene therapies

General Information
Company Name
NTrans Technologies BV
Founded Year
2015
Location (Offices)
The Netherlands +1
Founders / Decision Makers
Number of Employees
8
Industries
-
Funding Stage
-
Social Media

NTrans Technologies BV - Company Profile

Imagine a world where we conquer cancer and genetic diseases. At NTrans Technologies, we solve key challenges in cell and gene therapy: Delivering life-changing therapies to the right cells and tissues. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. Welcome to the next frontier of medicine. Our proprietary platform is GMP-ready and sets a new standard in cell and gene therapy. We use a non-viral delivery system to harness macropinocytosis - a natural cellular uptake process - for precise and secure delivery of gene-editing technologies. The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy. Please contact us at: [email protected]

Funding Rounds & Investors of NTrans Technologies BV (0)

View All

There is no investment information

Latest News of NTrans Technologies BV

View All

No recent news or press coverage available for NTrans Technologies BV.

Similar Companies to NTrans Technologies BV

View All
Basilard BioTech, Inc. - Similar company to NTrans Technologies BV
Basilard BioTech, Inc. Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies
Bionavigen - Similar company to NTrans Technologies BV
Bionavigen New Drug Development Through Smart Acquisition
Avectas  - Similar company to NTrans Technologies BV
Avectas Excelling beyond
Poseida Therapeutics, Inc. - Similar company to NTrans Technologies BV
Poseida Therapeutics, Inc. The Capacity to Cure